Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on July 1, 2008. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Tissue specimens from breast, colon , prostate, and lung cancer patients

Closed
NCI-80110-NGFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

Agency

N/A

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Malinda L HoldcraftContract Specialist

Full Description

Show more
The National Cancer Institute (NCI), a division of The National Institutes of Health (NIH) plans to procure on a sole source basis tissue specimens from breast, colon , prostate, and lung cancer patients, with Suburban Hospital Healthcare System 8300 Old Georgetown Road Bethesda, MD 20814. The supplies and services herein are being procured in accordance with the simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1). The North American Industry Classification code is 325414 and the business size standard is 500 employees. Period of Performance: It is anticipated that performance shall be for a twelve month period from the date of award. The NCI CCR is interested in defining the molecular profile of normal breast tissue from pre- and post- menopausal women of varying parity and in different phases of the menstrual cycle using genomic and proteomic techniques with the ultimate goal of identifying markers for cellular subtypes that could serve as therapeutic targets or biomarkers for prevention trials. Contractor Requirements: 1.)Provide specimens of normal breast tissue, primary and metastatic breast cancer lesions, pleural fluid from breast and lung cancer patients, and tissue from both prostate and colon cancer patients. 2.)Tissues shall be catalogued, processed and transported as specified in the NCI protocol. The Suburban Hospital Center is the only known source to the NCI with a reliable patient population able to provide both the type and quantity of specimens. Approximately 85% of these patients are currently involved in NCI clinical trials. The physical proximity of Suburban Hospital to the NIH campus ensures rapid delivery of fresh frozen samples as well as enabling patients that are enrolled in NCI clinical trials, to have easy access to and from NIH Clinical Center to Suburban Hospital. Changing variables at this time will interrupt the correct interpretations of clinical trials and research in progress. This is not a request for competitive quotation. However, if any interested party believes it can perform the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other furnished information must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform this requirement. An original and one copy of the capability statements must be received in the contracting office by 11 AM ET July 15, 2008. Faxed and E-mailed capability statements are not authorized. Questions must be submitted in writing to Malinda Holdcraft, Contract Specialist at Holdcram@exchange.nih.gov or by fax 301-402-4513. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive and award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Application (ORCA). Please reference solicitation number NCI-80110-NG on all correspondence.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS